Rankings
▼
Calendar
PLRX FY 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PLRX
Pliant Therapeutics, Inc.
$82M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
-81.9% YoY
Gross Profit
$8M
100.0% margin
Operating Income
-$98M
-1288.1% margin
Net Income
-$97M
-1284.5% margin
EPS (Diluted)
$-2.71
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$77M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$221M
Total Liabilities
$22M
Stockholders' Equity
$199M
Cash & Equivalents
$52M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$42M
-81.9%
Gross Profit
$8M
$42M
-81.9%
Operating Income
-$98M
-$42M
-134.2%
Net Income
-$97M
-$42M
-134.2%
← Q4 2020
All Quarters
Q1 2021 →